Overin Granüloza Hücreli Tümörlerinde Klinik Deneyimlerimiz
Amaç: Seks-kord stromal tümörler tüm over malignitelerinin yaklaşık olarak %5-8' ini oluştururlar ve bunlar içinde en sık görüleni granüloza hücreli tümörlerdir. Bu çalışmada; kliniğimizde granüloza hücreli tümör tanısı almış olgulardaki deneyimlerimiz incelenmiştir.Gereç ve yöntemler: Bu çalışmaya, hastanemiz jinekolojik onkoloji kliniğinde 2005-2009 yılları arasında opere edilen granüloza hücreli over tümörü olan 18 olgu dahil edildi. Bu olgular; tanı anındaki yaş, fertilite arzusu, tanıdaki semptomlar, endometrium durumu, parite, tümör evresi, tümör grade, tümör çapı, cerrahi tedavi şekli, adjuvan tedavi uygulanıp uygulanmadığı, sağ kalım, rekürrens ve ölüm açısından değerlendirildi.Bulgular: Olguların tanı anındaki ortalama yaşı 49 ± 15.4 yıl olarak hesaplandı. Tanı anındaki en sık semptomlar anormal uterin kanama (%72) ve abdominopelvik ağrı (%67) idi. Preoperatif değerlendirilmede 2 endometrial hiperplazi ve 1 endometrium kanseri tespit edilmişti. Olguların ortalama takip süresi 4.3 ± 1.4 yıl olarak hesaplandı. Olguların 13' ü (%72.2) evre I, 2' si (%11.1) evre II, 3' ü (%16.7) evre III olarak bulundu. Postoperatif adjuvan tedavi olguların 11' ine (%61) verilmişti. Takip süresinde %11 oranında nüks izlendi. Sonuçlar: Overin granüloza hücreli tümörleri nadir görülmektedir ve ilk tanıdan yıllar sonra bile nüks etme eğilimindedirler. Bu tümörlerin tedavisi cerrahidir ve fertilitesini devam ettirmek isteyen olgularda fertilite koruyucu cerrahi yapmak mümkündür. Bizim granüloza hücreli tümörlerle ilgili deneyimlerimiz literatür ile uyumludur. Ancak; bu konuda randomize çalışmaların azlığı nedeniyle konunun tüm yönleri net olarak ortaya konulamamıştır. Bu konuyla ilgili prospektif randomize çalışmalara ihtiyaç vardır
Our Clinical Experience in Granulosa Cell Tumors of the Ovary
Objective: Sex-cord-stromal tumors (SCSTs) represent approximately 5-8% of all ovarian malignancies. Granulosa cell tumors are the most common malignant tumors in the group of SCSTs. In this trial, we present our experiences in patients with granulosa cell tumor.Material and methods: 18 patients with granulosa cell tumor operated in our hospital between 2005 – 2009 are included and evaluated for age, wish for the preservation of fertility, symptoms, condition of endometrium, parity, stage of tumor, tumor grade, diameter of the tumor, type of surgical treatment, use of adjuvant treatment, survival, recurrence and mortality’.Results: Average age of the patients are 49 ± 15.4 . The most common symptoms were abnormal uterine bleeding (72%) and pelvic pain (67%) on admission. On preoperative evaluation, 2 endometrial hyperplasia and 1 endometrium cancer were diagnosed. The average follow-up time was 4.3 ± 1.4 years, 13 (72.2%), 2 (11.1%) and 3 (16.7%) of the patients presented with stage 1, 2 and 3, respectively. Postoperative adjuvant therapy was given to 11 of the patients (61%).Recurrence rate was 11% along follow up time. Conclusion: Granulosa cell tumors are rare tumors and may recurrence later. Surgery represents the most important therapeutic arm. Conservative surgery, preserving the possibility of a future pregnancy can be performed. Our experiences are coherent with literature. However, there is a lack of number of randomized clinical trials, and prospective randomized controlled trials are needed
___
- 1. Gershenson DM. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol. 1994;55(3 Pt 2):S62-72.
- 2. Young RH, Scully RE. Ovarian sex cord-stromal tumors. Problems in differential diagnosis. Pathol Annu. 1988;23 Pt 1:237-96.
- 3. Cronjé HS, Niemand I, Bam RH, Woodruff JD. Review of the granulosa-theca cell tumors from the emil Novak ovarian tumor registry. Am J Obstet Gynecol. 1999;180(2 Pt 1):323-7.
- 4. Young RH. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol. 2005;18 Suppl 2:S81–98.
- 5. Sehouli J, Drescher FS, Mustea A, Elling D, Friedmann W, Kühn W, et al. Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Res. 2004;24 (2C):1223–9.
- 6.Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol. 2007;25(20):2944–51.
- 7.Schumer ST, Cannistra SA. Granulosa cell tumor f the ovary. J Clin Oncol. 2003;21(6):1180-9.
- 8.Young RH, Dickersin DR, Scully RE. Juvenile granulosa cell tumor of the ovary: a clinicopathological analysis of 125 cases. Am J Surg Pathol. 1984;8(8):575-96.
- 9. Sehouli J, Drescher FS, Mustea A, Elling D, Friedmann W, Kühn W, et al. Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Res. 2004;24(2C):1223–9.
- 10. Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 1994;52(1):50–5.
- 11. Evans AT III, Gaffey TA, Malkasian GD Jr, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 1980;55(2):231-38.
- 12. Busquets M, Gonzalez-Bosquet E, Muchart J, Rovira C, Laïlla JM. Granulosa cell tumor and endometrial cancer: a case report and review of the literature. Eur J Gynaecol Oncol. 2010;31(5):575-8.
- 13. Aktaş S, Diniz G, Ortaç R, Ergin M, Erbay A. Sclerosing Stromal Tumor of the Ovary with Precocious Puberty in a Seven Month Old Girl: Case Report. Turkiye Klinikleri J Gynecol Obst 2009;19(2):98-101.
- 14. Pectasides D, Pectasides E, Psyrri A. Granulosa cell tumor of the ovary. Cancer Treat Rev. 2008;34(1):1-12.
- 15. Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary: an analysis of 376 women. Gynecol Oncol. 2007;104(2):396–400.
- 16. Fox H. Pathologic prognostic factors in early stage adult-type granulosa cell tumors of the ovary. Int J Gynecol Cancer. 2003;13(1):1-4.
- 17. Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Pectasides E, Mouratidou D, et al. Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res. 2008;28(2B):1421-7.
- 18. Bjorkholm E, Pettersson F. Granulosa-cell and theca-cell tumors: the clinical picture and long-term outcome for the Radiumhemmet series. Acta Obstet Gynecol Scand. 1980;59(4):361-5.
- 19. Miller K, McCluggage WG. Prognostic factors in ovarian adult granulosa cell tumour. J Clin Pathol. 2008;61(8):881-4.
- 20. Fontanelli R, Stefanon B, Raspagliesi F, Kenda R, Tomasic G, Spatti G, et al. Adult granulosa cell tumor of the ovary: a clinico pathologic study of 35 cases. Tumori. 1998;84(1):60-4.
- 21. Li W, Wu X, Fang C, Yao J, Guo Y, Zhang S. Prognostic factors in adult granulosa cell tumor of the ovary. Saudi Med J. 2009;30(2):247-52.
- 22. Miller BE, Barron BA, Wan JY, Delmore DE, Silva EG, Gershenson DM. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer. 1997;79(10):1951-5.
- 23. Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet LN. Granulosa cell tumors: a clinical review of 61 cases. Obstet Gynecol. 1978;52(6):718-23.
- 24. Ayhan A, Salman MC, Velipasaoglu M, Sakinci M, Yuce K. Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. Gynecol Oncol. 2009;20(3):158-63.
- 25. Vesco KK, Carney ME. Granulosa cell tumor of the ovary: extensive late recurrence after initial occult microscopic disease. Obstet Gynecol. 2002;99(5 pt 2):888-91.